EGFR and lung carcinoma: ✓ Promoter hypermethylation inversely correlates with expression levels.✓ High methylation levels at the PD-L1 promoter region are linked to the resistance to anti-PD-1 therapy in both chemotherapy or EGFR-TKI treated lung cancer patients.